<table style="border:1px solid #adadad; background-color: #F3F1EC; color: #666666; padding:8px; -webkit-border-radius:4px; border-radius:4px; -moz-border-radius:4px; line-height:16px; margin-bottom:6px;" width="100%">
        <tbody>
                <tr>
                        <td><span style="font-family:Helvetica, sans-serif; font-size:20px;font-weight:bold;">Science Daily Mind & Brain Daily Digest (Unofficial)</span></td>
                </tr>
                <tr>
                        <td> </td>
                </tr>
        </tbody>
</table>
<table style="font:13px Helvetica, sans-serif; border-radius:4px; -moz-border-radius:4px; -webkit-border-radius:4px; background-color:#fff; padding:8px; margin-bottom:6px; border:1px solid #adadad;" width="100%">
        <tbody>
                <tr>
                        <td><a href="https://www.sciencedaily.com/releases/2024/10/241017132114.htm" style="font-family:Helvetica, sans-serif; letter-spacing:-1px;margin:0;padding:0 0 2px;font-weight: bold;font-size: 19px;line-height: 20px;color:#222;">Repurposing drug shows promise in fighting aggressive brain tumors</a>
                        <div style="font-family:Helvetica, sans-serif; text-align:left;color:#999;font-size:11px;font-weight:bold;line-height:15px;">Oct 17th 2024, 13:21</div>

                        <div style="font-family:Helvetica, sans-serif; color:#494949;text-align:justify;font-size:13px;">
                        <p>Research provides evidence that a drug used to slow the progression of the disease ALS shows promise in suppressing the self-renewing cancerous stem cells that challenge the present standards of care for these lethal grade 4 brain tumours.</p>
                        </div>

                        <div style="font-family:Helvetica, sans-serif; font-size:13px; text-align: center; color: #666666; padding:4px; margin-bottom:2px;"></div>
                        </td>
                </tr>
        </tbody>
</table>
<p><strong>Forwarded by:<br />
Michael Reeder LCPC<br />
Baltimore, MD</strong></p>

<p><strong>This information is taken from free public RSS feeds published by each organization for the purpose of public distribution. Readers are linked back to the article content on each organization's website. This email is an unaffiliated unofficial redistribution of this freely provided content from the publishers. </strong></p>

<p> </p>

<p><s><small><a href="#" style="color:#ffffff;"><a href="https://blogtrottr.com/unsubscribe/565/QbcxgL">unsubscribe from this feed</a></a></small></s></p>